Idiosyncrasies of scalp melanoma

Laryngoscope

Volumn 117, Issue 8, 2007, Pages 1354-1358

  Rigual, Nestor R ^a   Cheney, Richard T ^a   Iwenofu, Obiajulu H ^a   Li, Qiang ^a   Loree, Thom R ^a   Popat, Saurin R ^a   Merzianu, Mihai ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Melanoma; Metastasis; Neck dissection; Outcomes; Scalp; Sentinel lymph node

Indexed keywords

EOSIN; HEMATOXYLIN; ISOSULFAN BLUE; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; PROTEIN S 100;

ADULT; AGED; ARTICLE; CANCER PATIENT; CERVICAL LYMPH NODE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; MORTALITY; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCALP TUMOR; SENTINEL LYMPH NODE; TUMOR RECURRENCE; ULCER;

ADOLESCENT; ADULT; AGED; ANTIGENS, NEOPLASM; CHILD; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NECK; NEOPLASM PROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES; S100 PROTEINS; SCALP; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548432573     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/mlg.0b013e31806146e5     Document Type: Article

References (23)

1. Urist MM, Balch CM, Soong SJ, et al. Head and neck melanoma in 534 clinical stage 1 patients. A prognostic factor analysis and results of surgical treatment. Ann Surg 1984;200:769-775.
2. O'Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991;162:310-314.
3. Melanoma of the skin. In: Green FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Handbook From the AJCC Cancer Staging Manual. New York: Springer-Verlag; 2002:239-254.
4. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-983.
5. Milton GW, Shaw HM, McCarthy WH, et al. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1,319 patients. Br J Surg 1982;69:108-111.
6. Medalie NS, Ackerman AB. Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis. Part I. Am J Dermatopathol 2003;25:399-417.
7. MacNeill KN, Ghazarian D, McCready D, et al. Sentinel lymph node biopsy for cutaneous melanoma of the head and neck. Ann Surg Oncol 2005;12:726-732.
8. Carlson GW, Murray DR, Lyles RH, et al. Sentinel lymph node biopsy in the management of cutaneous head and neck melanoma. Plastic Reconstr Surg 2005;115:721-728.
9. Pathak I, O'Brien CJ, Petersen-Schaeffer K, et al. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck 2001;23:785-790.
10. Lin D, Franc BL, Kashani-Sabet M, Singer MI. Lymphatic drainage patterns of the head and neck: cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. Head Neck 2006;28:249-255.
11. O'Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461-466.
12. Leong SP, Achtem TA, Habib FA, et al. Discordance between clinical predictions vs. lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma. Arch Dermatol 1999;135:1472-1476.
13. Loree TR, Spiro RH. Cutaneous melanoma of the head and neck. Am J Surg 1989;158:388-391.
14. Conley JJ. Management of malignant tumors of the scalp. Ann N Y Acad Sci 1964;114:976-984.
15. Wanebo HJ, Cooper PH, Young DV, et al. Prognostic factors in head and neck melanoma. Effect of lesion location. Cancer 1988;62:831-837.
16. Ballantyne AJ. Malignant melanoma of the skin of the head and neck. An analysis of 405 cases. Am J Surg 1970;120:425-431.
17. Day CL Jr, Mihm MC Jr, Sober AJ, et al. Prognostic factors for melanoma patients with lesions 0.76-1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg 1982;195:30-34.
18. Shumate CR, Carlson GW, Giacco GG, et al. The prognostic implications of location for scalp melanoma. Am J Surg 1991;162:315-319.
19. Close LG, Goepfert H, Ballantyne AJ, Jesse RH. Malignant melanoma of the scalp. Laryngoscope 1979;89:1189-1196.
20. Rhee D, Wenig BM, Smith RV. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck. Laryngoscope 2002;112:1970-1974.
21. Mangas C, Hilari JM, Paradelo C, et al. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase- polymerase chain reaction for tyrosinase in melanoma patients. Ann Surg Onc 2006;13:910-918.
22. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001;91:2110-2121
23. Spanknebel K, Coit DG, Bieligk SC, et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 2005;29:305-317.